Report Overview
Mycoplasma diagnostics is a class of medical tests or examination conducted to evaluate nucleic acids or proteins at a molecular level. This aids in the early detection of mycoplasma contaminations in samples. Mycoplasma diagnostics is considered as a rapidly evolving and fast growing segment in the in-vitro diagnostic industry. Usually, usage of molecular diagnostics was limited due to necessity of vastly skilled specialists and high cost of tests.
The global Mycoplasma Diagnostics market size was estimated at USD 729.90 million in 2023 and is projected to reach USD 1132.31 million by 2032, exhibiting a CAGR of 5.00% during the forecast period.
North America Mycoplasma Diagnostics market size was estimated at USD 206.84 million in 2023, at a CAGR of 4.29% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Mycoplasma Diagnostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Mycoplasma Diagnostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Mycoplasma Diagnostics market in any manner.
Global Mycoplasma Diagnostics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Agilent Technologies
Thermo Fisher Scientific
PromoCell
Charles River Laboratories International
Merck KGaA
Lonza Group
Takara Bio (Takara Holding Company.)
Savyon Diagnostics
Tecan Trading (Tecan Group)
Sartorius Stedim BioOutsource
American Type Culture Collection (ATCC)
F Hoffmann-La Roche
Market Segmentation (by Type)
Kits & Reagents
Instruments
Software & Services
Market Segmentation (by Application)
Hospitals
Diagnostic Laboratories
Clinics
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Mycoplasma Diagnostics Market
Overview of the regional outlook of the Mycoplasma Diagnostics Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Mycoplasma Diagnostics
1.2 Key Market Segments
1.2.1 Mycoplasma Diagnostics Segment by Type
1.2.2 Mycoplasma Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Mycoplasma Diagnostics Market Overview
2.1 Global Market Overview
2.1.1 Global Mycoplasma Diagnostics Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Mycoplasma Diagnostics Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Mycoplasma Diagnostics Market Competitive Landscape
3.1 Global Mycoplasma Diagnostics Sales by Manufacturers (2019-2025)
3.2 Global Mycoplasma Diagnostics Revenue Market Share by Manufacturers (2019-2025)
3.3 Mycoplasma Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Mycoplasma Diagnostics Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Mycoplasma Diagnostics Sales Sites, Area Served, Product Type
3.6 Mycoplasma Diagnostics Market Competitive Situation and Trends
3.6.1 Mycoplasma Diagnostics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Mycoplasma Diagnostics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Mycoplasma Diagnostics Industry Chain Analysis
4.1 Mycoplasma Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Mycoplasma Diagnostics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Mycoplasma Diagnostics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Mycoplasma Diagnostics Sales Market Share by Type (2019-2025)
6.3 Global Mycoplasma Diagnostics Market Size Market Share by Type (2019-2025)
6.4 Global Mycoplasma Diagnostics Price by Type (2019-2025)
7 Mycoplasma Diagnostics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Mycoplasma Diagnostics Market Sales by Application (2019-2025)
7.3 Global Mycoplasma Diagnostics Market Size (M USD) by Application (2019-2025)
7.4 Global Mycoplasma Diagnostics Sales Growth Rate by Application (2019-2025)
8 Mycoplasma Diagnostics Market Consumption by Region
8.1 Global Mycoplasma Diagnostics Sales by Region
8.1.1 Global Mycoplasma Diagnostics Sales by Region
8.1.2 Global Mycoplasma Diagnostics Sales Market Share by Region
8.2 North America
8.2.1 North America Mycoplasma Diagnostics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Mycoplasma Diagnostics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Mycoplasma Diagnostics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Mycoplasma Diagnostics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Mycoplasma Diagnostics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Mycoplasma Diagnostics Market Production by Region
9.1 Global Production of Mycoplasma Diagnostics by Region (2019-2025)
9.2 Global Mycoplasma Diagnostics Revenue Market Share by Region (2019-2025)
9.3 Global Mycoplasma Diagnostics Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Mycoplasma Diagnostics Production
9.4.1 North America Mycoplasma Diagnostics Production Growth Rate (2019-2025)
9.4.2 North America Mycoplasma Diagnostics Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Mycoplasma Diagnostics Production
9.5.1 Europe Mycoplasma Diagnostics Production Growth Rate (2019-2025)
9.5.2 Europe Mycoplasma Diagnostics Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Mycoplasma Diagnostics Production (2019-2025)
9.6.1 Japan Mycoplasma Diagnostics Production Growth Rate (2019-2025)
9.6.2 Japan Mycoplasma Diagnostics Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Mycoplasma Diagnostics Production (2019-2025)
9.7.1 China Mycoplasma Diagnostics Production Growth Rate (2019-2025)
9.7.2 China Mycoplasma Diagnostics Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Agilent Technologies
10.1.1 Agilent Technologies Mycoplasma Diagnostics Basic Information
10.1.2 Agilent Technologies Mycoplasma Diagnostics Product Overview
10.1.3 Agilent Technologies Mycoplasma Diagnostics Product Market Performance
10.1.4 Agilent Technologies Business Overview
10.1.5 Agilent Technologies Mycoplasma Diagnostics SWOT Analysis
10.1.6 Agilent Technologies Recent Developments
10.2 Thermo Fisher Scientific
10.2.1 Thermo Fisher Scientific Mycoplasma Diagnostics Basic Information
10.2.2 Thermo Fisher Scientific Mycoplasma Diagnostics Product Overview
10.2.3 Thermo Fisher Scientific Mycoplasma Diagnostics Product Market Performance
10.2.4 Thermo Fisher Scientific Business Overview
10.2.5 Thermo Fisher Scientific Mycoplasma Diagnostics SWOT Analysis
10.2.6 Thermo Fisher Scientific Recent Developments
10.3 PromoCell
10.3.1 PromoCell Mycoplasma Diagnostics Basic Information
10.3.2 PromoCell Mycoplasma Diagnostics Product Overview
10.3.3 PromoCell Mycoplasma Diagnostics Product Market Performance
10.3.4 PromoCell Mycoplasma Diagnostics SWOT Analysis
10.3.5 PromoCell Business Overview
10.3.6 PromoCell Recent Developments
10.4 Charles River Laboratories International
10.4.1 Charles River Laboratories International Mycoplasma Diagnostics Basic Information
10.4.2 Charles River Laboratories International Mycoplasma Diagnostics Product Overview
10.4.3 Charles River Laboratories International Mycoplasma Diagnostics Product Market Performance
10.4.4 Charles River Laboratories International Business Overview
10.4.5 Charles River Laboratories International Recent Developments
10.5 Merck KGaA
10.5.1 Merck KGaA Mycoplasma Diagnostics Basic Information
10.5.2 Merck KGaA Mycoplasma Diagnostics Product Overview
10.5.3 Merck KGaA Mycoplasma Diagnostics Product Market Performance
10.5.4 Merck KGaA Business Overview
10.5.5 Merck KGaA Recent Developments
10.6 Lonza Group
10.6.1 Lonza Group Mycoplasma Diagnostics Basic Information
10.6.2 Lonza Group Mycoplasma Diagnostics Product Overview
10.6.3 Lonza Group Mycoplasma Diagnostics Product Market Performance
10.6.4 Lonza Group Business Overview
10.6.5 Lonza Group Recent Developments
10.7 Takara Bio (Takara Holding Company.)
10.7.1 Takara Bio (Takara Holding Company.) Mycoplasma Diagnostics Basic Information
10.7.2 Takara Bio (Takara Holding Company.) Mycoplasma Diagnostics Product Overview
10.7.3 Takara Bio (Takara Holding Company.) Mycoplasma Diagnostics Product Market Performance
10.7.4 Takara Bio (Takara Holding Company.) Business Overview
10.7.5 Takara Bio (Takara Holding Company.) Recent Developments
10.8 Savyon Diagnostics
10.8.1 Savyon Diagnostics Mycoplasma Diagnostics Basic Information
10.8.2 Savyon Diagnostics Mycoplasma Diagnostics Product Overview
10.8.3 Savyon Diagnostics Mycoplasma Diagnostics Product Market Performance
10.8.4 Savyon Diagnostics Business Overview
10.8.5 Savyon Diagnostics Recent Developments
10.9 Tecan Trading (Tecan Group)
10.9.1 Tecan Trading (Tecan Group) Mycoplasma Diagnostics Basic Information
10.9.2 Tecan Trading (Tecan Group) Mycoplasma Diagnostics Product Overview
10.9.3 Tecan Trading (Tecan Group) Mycoplasma Diagnostics Product Market Performance
10.9.4 Tecan Trading (Tecan Group) Business Overview
10.9.5 Tecan Trading (Tecan Group) Recent Developments
10.10 Sartorius Stedim BioOutsource
10.10.1 Sartorius Stedim BioOutsource Mycoplasma Diagnostics Basic Information
10.10.2 Sartorius Stedim BioOutsource Mycoplasma Diagnostics Product Overview
10.10.3 Sartorius Stedim BioOutsource Mycoplasma Diagnostics Product Market Performance
10.10.4 Sartorius Stedim BioOutsource Business Overview
10.10.5 Sartorius Stedim BioOutsource Recent Developments
10.11 American Type Culture Collection (ATCC)
10.11.1 American Type Culture Collection (ATCC) Mycoplasma Diagnostics Basic Information
10.11.2 American Type Culture Collection (ATCC) Mycoplasma Diagnostics Product Overview
10.11.3 American Type Culture Collection (ATCC) Mycoplasma Diagnostics Product Market Performance
10.11.4 American Type Culture Collection (ATCC) Business Overview
10.11.5 American Type Culture Collection (ATCC) Recent Developments
10.12 F Hoffmann-La Roche
10.12.1 F Hoffmann-La Roche Mycoplasma Diagnostics Basic Information
10.12.2 F Hoffmann-La Roche Mycoplasma Diagnostics Product Overview
10.12.3 F Hoffmann-La Roche Mycoplasma Diagnostics Product Market Performance
10.12.4 F Hoffmann-La Roche Business Overview
10.12.5 F Hoffmann-La Roche Recent Developments
11 Mycoplasma Diagnostics Market Forecast by Region
11.1 Global Mycoplasma Diagnostics Market Size Forecast
11.2 Global Mycoplasma Diagnostics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Mycoplasma Diagnostics Market Size Forecast by Country
11.2.3 Asia Pacific Mycoplasma Diagnostics Market Size Forecast by Region
11.2.4 South America Mycoplasma Diagnostics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Mycoplasma Diagnostics by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Mycoplasma Diagnostics Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Mycoplasma Diagnostics by Type (2025-2032)
12.1.2 Global Mycoplasma Diagnostics Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Mycoplasma Diagnostics by Type (2025-2032)
12.2 Global Mycoplasma Diagnostics Market Forecast by Application (2025-2032)
12.2.1 Global Mycoplasma Diagnostics Sales (K Units) Forecast by Application
12.2.2 Global Mycoplasma Diagnostics Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Mycoplasma Diagnostics Market Size Comparison by Region (M USD)
Table 5. Global Mycoplasma Diagnostics Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Mycoplasma Diagnostics Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Mycoplasma Diagnostics Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Mycoplasma Diagnostics Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mycoplasma Diagnostics as of 2022)
Table 10. Global Market Mycoplasma Diagnostics Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Mycoplasma Diagnostics Sales Sites and Area Served
Table 12. Manufacturers Mycoplasma Diagnostics Product Type
Table 13. Global Mycoplasma Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Mycoplasma Diagnostics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Mycoplasma Diagnostics Market Challenges
Table 22. Global Mycoplasma Diagnostics Sales by Type (K Units)
Table 23. Global Mycoplasma Diagnostics Market Size by Type (M USD)
Table 24. Global Mycoplasma Diagnostics Sales (K Units) by Type (2019-2025)
Table 25. Global Mycoplasma Diagnostics Sales Market Share by Type (2019-2025)
Table 26. Global Mycoplasma Diagnostics Market Size (M USD) by Type (2019-2025)
Table 27. Global Mycoplasma Diagnostics Market Size Share by Type (2019-2025)
Table 28. Global Mycoplasma Diagnostics Price (USD/Unit) by Type (2019-2025)
Table 29. Global Mycoplasma Diagnostics Sales (K Units) by Application
Table 30. Global Mycoplasma Diagnostics Market Size by Application
Table 31. Global Mycoplasma Diagnostics Sales by Application (2019-2025) & (K Units)
Table 32. Global Mycoplasma Diagnostics Sales Market Share by Application (2019-2025)
Table 33. Global Mycoplasma Diagnostics Sales by Application (2019-2025) & (M USD)
Table 34. Global Mycoplasma Diagnostics Market Share by Application (2019-2025)
Table 35. Global Mycoplasma Diagnostics Sales Growth Rate by Application (2019-2025)
Table 36. Global Mycoplasma Diagnostics Sales by Region (2019-2025) & (K Units)
Table 37. Global Mycoplasma Diagnostics Sales Market Share by Region (2019-2025)
Table 38. North America Mycoplasma Diagnostics Sales by Country (2019-2025) & (K Units)
Table 39. Europe Mycoplasma Diagnostics Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Mycoplasma Diagnostics Sales by Region (2019-2025) & (K Units)
Table 41. South America Mycoplasma Diagnostics Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Mycoplasma Diagnostics Sales by Region (2019-2025) & (K Units)
Table 43. Global Mycoplasma Diagnostics Production (K Units) by Region (2019-2025)
Table 44. Global Mycoplasma Diagnostics Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Mycoplasma Diagnostics Revenue Market Share by Region (2019-2025)
Table 46. Global Mycoplasma Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Mycoplasma Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Mycoplasma Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Mycoplasma Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Mycoplasma Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. Agilent Technologies Mycoplasma Diagnostics Basic Information
Table 52. Agilent Technologies Mycoplasma Diagnostics Product Overview
Table 53. Agilent Technologies Mycoplasma Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. Agilent Technologies Business Overview
Table 55. Agilent Technologies Mycoplasma Diagnostics SWOT Analysis
Table 56. Agilent Technologies Recent Developments
Table 57. Thermo Fisher Scientific Mycoplasma Diagnostics Basic Information
Table 58. Thermo Fisher Scientific Mycoplasma Diagnostics Product Overview
Table 59. Thermo Fisher Scientific Mycoplasma Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. Thermo Fisher Scientific Business Overview
Table 61. Thermo Fisher Scientific Mycoplasma Diagnostics SWOT Analysis
Table 62. Thermo Fisher Scientific Recent Developments
Table 63. PromoCell Mycoplasma Diagnostics Basic Information
Table 64. PromoCell Mycoplasma Diagnostics Product Overview
Table 65. PromoCell Mycoplasma Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. PromoCell Mycoplasma Diagnostics SWOT Analysis
Table 67. PromoCell Business Overview
Table 68. PromoCell Recent Developments
Table 69. Charles River Laboratories International Mycoplasma Diagnostics Basic Information
Table 70. Charles River Laboratories International Mycoplasma Diagnostics Product Overview
Table 71. Charles River Laboratories International Mycoplasma Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Charles River Laboratories International Business Overview
Table 73. Charles River Laboratories International Recent Developments
Table 74. Merck KGaA Mycoplasma Diagnostics Basic Information
Table 75. Merck KGaA Mycoplasma Diagnostics Product Overview
Table 76. Merck KGaA Mycoplasma Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. Merck KGaA Business Overview
Table 78. Merck KGaA Recent Developments
Table 79. Lonza Group Mycoplasma Diagnostics Basic Information
Table 80. Lonza Group Mycoplasma Diagnostics Product Overview
Table 81. Lonza Group Mycoplasma Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. Lonza Group Business Overview
Table 83. Lonza Group Recent Developments
Table 84. Takara Bio (Takara Holding Company.) Mycoplasma Diagnostics Basic Information
Table 85. Takara Bio (Takara Holding Company.) Mycoplasma Diagnostics Product Overview
Table 86. Takara Bio (Takara Holding Company.) Mycoplasma Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Takara Bio (Takara Holding Company.) Business Overview
Table 88. Takara Bio (Takara Holding Company.) Recent Developments
Table 89. Savyon Diagnostics Mycoplasma Diagnostics Basic Information
Table 90. Savyon Diagnostics Mycoplasma Diagnostics Product Overview
Table 91. Savyon Diagnostics Mycoplasma Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Savyon Diagnostics Business Overview
Table 93. Savyon Diagnostics Recent Developments
Table 94. Tecan Trading (Tecan Group) Mycoplasma Diagnostics Basic Information
Table 95. Tecan Trading (Tecan Group) Mycoplasma Diagnostics Product Overview
Table 96. Tecan Trading (Tecan Group) Mycoplasma Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Tecan Trading (Tecan Group) Business Overview
Table 98. Tecan Trading (Tecan Group) Recent Developments
Table 99. Sartorius Stedim BioOutsource Mycoplasma Diagnostics Basic Information
Table 100. Sartorius Stedim BioOutsource Mycoplasma Diagnostics Product Overview
Table 101. Sartorius Stedim BioOutsource Mycoplasma Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. Sartorius Stedim BioOutsource Business Overview
Table 103. Sartorius Stedim BioOutsource Recent Developments
Table 104. American Type Culture Collection (ATCC) Mycoplasma Diagnostics Basic Information
Table 105. American Type Culture Collection (ATCC) Mycoplasma Diagnostics Product Overview
Table 106. American Type Culture Collection (ATCC) Mycoplasma Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 107. American Type Culture Collection (ATCC) Business Overview
Table 108. American Type Culture Collection (ATCC) Recent Developments
Table 109. F Hoffmann-La Roche Mycoplasma Diagnostics Basic Information
Table 110. F Hoffmann-La Roche Mycoplasma Diagnostics Product Overview
Table 111. F Hoffmann-La Roche Mycoplasma Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 112. F Hoffmann-La Roche Business Overview
Table 113. F Hoffmann-La Roche Recent Developments
Table 114. Global Mycoplasma Diagnostics Sales Forecast by Region (2025-2032) & (K Units)
Table 115. Global Mycoplasma Diagnostics Market Size Forecast by Region (2025-2032) & (M USD)
Table 116. North America Mycoplasma Diagnostics Sales Forecast by Country (2025-2032) & (K Units)
Table 117. North America Mycoplasma Diagnostics Market Size Forecast by Country (2025-2032) & (M USD)
Table 118. Europe Mycoplasma Diagnostics Sales Forecast by Country (2025-2032) & (K Units)
Table 119. Europe Mycoplasma Diagnostics Market Size Forecast by Country (2025-2032) & (M USD)
Table 120. Asia Pacific Mycoplasma Diagnostics Sales Forecast by Region (2025-2032) & (K Units)
Table 121. Asia Pacific Mycoplasma Diagnostics Market Size Forecast by Region (2025-2032) & (M USD)
Table 122. South America Mycoplasma Diagnostics Sales Forecast by Country (2025-2032) & (K Units)
Table 123. South America Mycoplasma Diagnostics Market Size Forecast by Country (2025-2032) & (M USD)
Table 124. Middle East and Africa Mycoplasma Diagnostics Consumption Forecast by Country (2025-2032) & (Units)
Table 125. Middle East and Africa Mycoplasma Diagnostics Market Size Forecast by Country (2025-2032) & (M USD)
Table 126. Global Mycoplasma Diagnostics Sales Forecast by Type (2025-2032) & (K Units)
Table 127. Global Mycoplasma Diagnostics Market Size Forecast by Type (2025-2032) & (M USD)
Table 128. Global Mycoplasma Diagnostics Price Forecast by Type (2025-2032) & (USD/Unit)
Table 129. Global Mycoplasma Diagnostics Sales (K Units) Forecast by Application (2025-2032)
Table 130. Global Mycoplasma Diagnostics Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Mycoplasma Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Mycoplasma Diagnostics Market Size (M USD), 2019-2032
Figure 5. Global Mycoplasma Diagnostics Market Size (M USD) (2019-2032)
Figure 6. Global Mycoplasma Diagnostics Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Mycoplasma Diagnostics Market Size by Country (M USD)
Figure 11. Mycoplasma Diagnostics Sales Share by Manufacturers in 2023
Figure 12. Global Mycoplasma Diagnostics Revenue Share by Manufacturers in 2023
Figure 13. Mycoplasma Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Mycoplasma Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Mycoplasma Diagnostics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Mycoplasma Diagnostics Market Share by Type
Figure 18. Sales Market Share of Mycoplasma Diagnostics by Type (2019-2025)
Figure 19. Sales Market Share of Mycoplasma Diagnostics by Type in 2023
Figure 20. Market Size Share of Mycoplasma Diagnostics by Type (2019-2025)
Figure 21. Market Size Market Share of Mycoplasma Diagnostics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Mycoplasma Diagnostics Market Share by Application
Figure 24. Global Mycoplasma Diagnostics Sales Market Share by Application (2019-2025)
Figure 25. Global Mycoplasma Diagnostics Sales Market Share by Application in 2023
Figure 26. Global Mycoplasma Diagnostics Market Share by Application (2019-2025)
Figure 27. Global Mycoplasma Diagnostics Market Share by Application in 2023
Figure 28. Global Mycoplasma Diagnostics Sales Growth Rate by Application (2019-2025)
Figure 29. Global Mycoplasma Diagnostics Sales Market Share by Region (2019-2025)
Figure 30. North America Mycoplasma Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Mycoplasma Diagnostics Sales Market Share by Country in 2023
Figure 32. U.S. Mycoplasma Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Mycoplasma Diagnostics Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Mycoplasma Diagnostics Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Mycoplasma Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Mycoplasma Diagnostics Sales Market Share by Country in 2023
Figure 37. Germany Mycoplasma Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Mycoplasma Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Mycoplasma Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Mycoplasma Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Mycoplasma Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Mycoplasma Diagnostics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Mycoplasma Diagnostics Sales Market Share by Region in 2023
Figure 44. China Mycoplasma Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Mycoplasma Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Mycoplasma Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Mycoplasma Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Mycoplasma Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Mycoplasma Diagnostics Sales and Growth Rate (K Units)
Figure 50. South America Mycoplasma Diagnostics Sales Market Share by Country in 2023
Figure 51. Brazil Mycoplasma Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Mycoplasma Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Mycoplasma Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Mycoplasma Diagnostics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Mycoplasma Diagnostics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Mycoplasma Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Mycoplasma Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Mycoplasma Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Mycoplasma Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Mycoplasma Diagnostics Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Mycoplasma Diagnostics Production Market Share by Region (2019-2025)
Figure 62. North America Mycoplasma Diagnostics Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Mycoplasma Diagnostics Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Mycoplasma Diagnostics Production (K Units) Growth Rate (2019-2025)
Figure 65. China Mycoplasma Diagnostics Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Mycoplasma Diagnostics Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Mycoplasma Diagnostics Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Mycoplasma Diagnostics Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Mycoplasma Diagnostics Market Share Forecast by Type (2025-2032)
Figure 70. Global Mycoplasma Diagnostics Sales Forecast by Application (2025-2032)
Figure 71. Global Mycoplasma Diagnostics Market Share Forecast by Application (2025-2032)
